AR013749A1 - Tratamiento de retinopatia diabetica - Google Patents

Tratamiento de retinopatia diabetica

Info

Publication number
AR013749A1
AR013749A1 ARP980105654A ARP980105654A AR013749A1 AR 013749 A1 AR013749 A1 AR 013749A1 AR P980105654 A ARP980105654 A AR P980105654A AR P980105654 A ARP980105654 A AR P980105654A AR 013749 A1 AR013749 A1 AR 013749A1
Authority
AR
Argentina
Prior art keywords
treatment
diabetic retinopathy
elliprodil
glutamate
antagonist compositions
Prior art date
Application number
ARP980105654A
Other languages
English (en)
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of AR013749A1 publication Critical patent/AR013749A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el uso de composiciones de antagonistas de excitotoxicidad inducida por glutamato para el tratamiento de retinopatía diabética tal comoeleliprodil.
ARP980105654A 1997-11-14 1998-11-09 Tratamiento de retinopatia diabetica AR013749A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6569497P 1997-11-14 1997-11-14

Publications (1)

Publication Number Publication Date
AR013749A1 true AR013749A1 (es) 2001-01-10

Family

ID=22064483

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105654A AR013749A1 (es) 1997-11-14 1998-11-09 Tratamiento de retinopatia diabetica

Country Status (4)

Country Link
AR (1) AR013749A1 (es)
AU (1) AU9797598A (es)
WO (1) WO1999025350A1 (es)
ZA (1) ZA989514B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
BRPI0513862A (pt) * 2004-07-26 2008-05-20 Allergan Inc métodos de tratar condições oftálmicas
US20070203144A1 (en) * 2006-01-17 2007-08-30 Allergan, Inc. Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
WO2011112243A2 (en) * 2010-03-08 2011-09-15 The University Of Tennessee Research Foundation Beta -adrenergic receptor agonists and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006118A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
FR2738568B1 (fr) * 1995-09-08 1997-10-17 Synthelabo Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique
WO1997038691A1 (fr) * 1996-04-17 1997-10-23 Sumitomo Pharmaceuticals Co., Ltd. Medicament pour neuropathie retinienne

Also Published As

Publication number Publication date
AU9797598A (en) 1999-06-07
ZA989514B (en) 1999-06-15
WO1999025350A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
GT199900217A (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
BR0215405A (pt) Composições e processos de uso de collajolie
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ES2195970T3 (es) L-ribavirina y usos de la misma.
BR9900320A (pt) Composição antimicrobiana
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
ES2176795T3 (es) Composiciones a base de esfingomielanasa y su utilizacion.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
SE9802729D0 (sv) Novel Compounds
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
ES2202855T3 (es) Uso de antagonistas 5ht3 para promover el lavado intestinal.
IT1285770B1 (it) Composti corticoidei
MX17808A (es) Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos
BR9909486A (pt) Compostos calcilìticos
ES2163867T3 (es) Composicion para el control del polvo.
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SE9801494D0 (sv) Novel use
CO4230021A1 (es) Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
AR013749A1 (es) Tratamiento de retinopatia diabetica
DK1250337T3 (da) Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter
DE69936052D1 (de) N1 modifizierte glycopeptide